Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer.
Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practic